Beijing Boren Hospital

Beijing Boren Hospital is a specialized tertiary medical institution in Beijing, China, focusing on hematology, oncology, and bone marrow transplantation. As a flagship facility of the GoBroad Healthcare Group, it has gained international prominence for its pioneering work in cellular immunotherapy, specifically Chimeric Antigen Receptor T-cell (CAR-T) therapies for refractory and relapsed blood cancers. The hospital integrates advanced diagnostic laboratories with clinical care, offering comprehensive treatment for leukemia, lymphoma, and multiple myeloma. It serves as a major hub for clinical research, conducting numerous investigator-initiated and industry-sponsored trials that bridge the gap between laboratory discovery and clinical application.